Abstract
Ther-PO-17 - Transitioning to pegylated interferon for the treatment of cutaneous T-cell lymphoma: meeting the challenge of therapy discontinuation and a proposed algorithm
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
